As a consequence, the phase III studies worked with much higher doses. γ-Secretase has other targets, for example the notch receptor.
Iz toj razloga, studije faze III se sprovode sa znatno većim dozama. γ-sekretaza ima druge supstrate, na primer Notch receptor.